These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25190440)

  • 1. Acute ischemic stroke and long-term outcome after thrombolysis: nationwide propensity score-matched follow-up study.
    Schmitz ML; Simonsen CZ; Hundborg H; Christensen H; Ellemann K; Geisler K; Iversen H; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
    Stroke; 2014 Oct; 45(10):3070-2. PubMed ID: 25190440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study.
    Terkelsen T; Schmitz ML; Simonsen CZ; Hundborg HH; Christensen HK; Gyllenborg J; Sandal BF; Iversen HK; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
    Int J Stroke; 2016 Oct; 11(8):910-916. PubMed ID: 27312677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis.
    Yu AYX; Fang J; Kapral MK
    Stroke; 2019 Dec; 50(12):3488-3493. PubMed ID: 31570086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
    Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
    Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Prognosis in Ischemic Stroke Patients Treated with Intravenous Thrombolytic Therapy.
    Stefanovic Budimkic M; Pekmezovic T; Beslac-Bumbasirevic L; Ercegovac M; Berisavac I; Stanarcevic P; Padjen V; Jovanović DR
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):196-203. PubMed ID: 28341074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age.
    Arora R; Salamon E; Katz JM; Cox M; Saver JL; Bhatt DL; Fonarow GC; Peterson ED; Smith EE; Schwamm LH; Xian Y; Libman RB
    Stroke; 2016 Sep; 47(9):2347-54. PubMed ID: 27491734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy.
    Heuschmann PU; Kolominsky-Rabas PL; Roether J; Misselwitz B; Lowitzsch K; Heidrich J; Hermanek P; Leffmann C; Sitzer M; Biegler M; Buecker-Nott HJ; Berger K;
    JAMA; 2004 Oct; 292(15):1831-8. PubMed ID: 15494580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term mortality after intravenous thrombolysis for acute ischemic stroke: A propensity score-matched cohort with 5-year follow-up.
    Heo NH; Lee MR; Yang KH; Hong OR; Shin JH; Lee BY; Lee JY; Ahn JM; Oh HJ; Oh JS
    Medicine (Baltimore); 2021 Nov; 100(44):e27652. PubMed ID: 34871239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Survival After Intravenous Thrombolysis for Ischemic Stroke: A Propensity Score-Matched Cohort With up to 10-Year Follow-Up.
    Muruet W; Rudd A; Wolfe CDA; Douiri A
    Stroke; 2018 Mar; 49(3):607-613. PubMed ID: 29440582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
    Lubeck DP; Danese MD; Duryea J; Halperin M; Tayama D; Yu E; Lalla D; Grotta JC
    Int J Stroke; 2016 Feb; 11(2):198-205. PubMed ID: 26783311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.